GlobeNewswire Inc | Nov 6, 2020 08:30AM EST

November 06, 2020

NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company) today provided an update on the development of an eProcurement platform, supply-chain-management software and telemedicine software for the healthcare industry by its wholly-owned subsidiary, Dalian BOYI Technology Co., Ltd.

As initially disclosed on February 21, 2020, BOYI Technology was established to develop and market software for the healthcare industry including, an eProcurement platform, supply-chain-management software, telemedicine software and chronic care management systems. To align with BIMIs plans for the future including its proposed online to offline business model, BOYI Technology has revised its strategy. Going forward, BOYI Technology intends to merge a chronic care management module into telemedicine software. In addition, BOYI Technology plans to develop solutions for hospitals and other healthcare institutions that will integrate and utilize both online and offline resources.

In addition, to support BIMIs operation, BOYI Technology has developed a new website for BIMI at www.usbimi.com, displaying the Companys profile, core business, investor relations, news center, corporate culture, contacts, and other general information.

BOYI Technologys information technologies rely on cloud computing clusters and big data intelligent analysis. These programs can facilitate the transition from traditional medical institutions to internet-based institutions as well as enable the switch from the traditional manual diagnosis to AI intelligent diagnosis. I believe that our healthcare technologies can improve the efficiency of medical institutions and meet the increasing market demand for telehealth and daily medical needs. Said Mr. Tiewei Song, Chief Executive Officer and President of BOQI International Medical Inc.



About BOQI International Medical Inc.

BOQI International Medical Inc. (formerly known as NF Energy Saving Corporation) (NASDAQ: BIMI) was founded in 2006. In February 2019, the Board of Directors of the company was reorganized with a focus on the health industry. The Company is now exclusively a healthcare products provider, offering a broad range of healthcare products and related services. For more information about BOQI International Medical, please visit www.usbimi.com.

Safe Harbor Statement

Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Companys ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of the Coronavirus (COVID-19), the demand for the Companys products and the Companys customers economic condition, risk of operations in the Peoples Republic of China, general economic conditions and other risk factors detailed in the Companys annual report and other filings with the United States Securities and Exchange Commission. Investors are urged to read the Companys Quarterly Report on Form 10-Q for the three months ended March 31, 2020 for further information about the Companys financial results, liquidity and capital resources.

IR Contact:

Dragon Gate Investment Partners LLCTel: +1(646)-801-2803Email: BIMI@dgipl.com